Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Geron Corporation

Tracked across 2 events · 13 articles · First seen Mar 13, 2025 · Last active Jul 22, 2026

Sentiment
35
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: Geron Corporation announced positive real-world evidence study results for its drug RYTELO (imetelstat) in lower-risk myelodysplastic syndromes (LR-MDS), which supports its continued use and potential for expanded treatment options.
May 12, 2026 · 6 articles
0 0
Business
Impact: Geron granted stock options to new employees as inducements, a standard practice for attracting talent. The grants are non-dilutive in the short term and align with Nasdaq rules.
Jul 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Geron Corporation live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.